New FDA-Approved Diabetes Drug Slashes Heart Attack and Stroke Risk

Sotagliflozin considerably reduces coronary heart assaults and strokes in high-risk sufferers with diabetes and kidney illness, providing a brand new therapy choice for cardiovascular safety. Sotagliflozin, a not too long ago FDA-approved drug for treating kind 2 diabetes and kidney illness in sufferers with extra cardiovascular threat elements, has been proven to considerably cut back the chance of coronary heart assault and […]



Source link